Henry Ford Cancer-Detroit — Detroit, Michigan

Henry Ford Cancer-Detroit is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Henry Ford Cancer-Detroit has participated in 16 clinical trials with 16 currently active.

Therapeutic areas: Gastrointestinal Cancer, Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Sponsors: Henry Ford Health System, TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Bindu R Potugari.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer-Detroit?

Henry Ford Cancer-Detroit has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer-Detroit conducted?

Henry Ford Cancer-Detroit has 16 clinical trials on record, with 16 currently active. Their work covers Gastrointestinal Cancer, Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Is Henry Ford Cancer-Detroit accredited by Crixeo Clinical Trials?

Henry Ford Cancer-Detroit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer-Detroit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.